1Giacco F, Brownlee M. Oxidative stress and diabetic complieations[J]. Circulation Research, 2010, 107(9) : 1058-1070. 被引量：1
2Guldiken B, Demir M, Guldiken S, et al. Oxidative stress and total an- tioxidant capacity in diabetic and nondiabetic acute ischemic stroke pa- tients[ J ]. Clinical and Applied Thrombosis-Hemostasis, 2009, 15 (6) : 695-700. 被引量：1
3di Lisa F, Kaludercic N, Cappi A, et al. Mitochondria and vascular pa- thology[J]. Pharmacological Reports, 2009, 61 ( 1 ) : 123-130. 被引量：1
4Thandavarayan RA, Watanabe K, Ma MA, et al. Dominant-negative p38 alpha mitogen-aetivated protein kinase prevents cardiac apoptosis and remodeling after streptozotocin-induced diabetes mellitus[ J]. Am J Physiol Heart Circular Physiol, 2009, 297 (3) : H911-H919. 被引量：1
5Kuroda J, Ago T, Matsushima S, et al. NADPH oxidase 4 (Nox4) is a major source of oxidative stress in the failing heart[J]. Pro N A Sci U S A, 2010, 107(35): 15565-15570. 被引量：1
6Maalouf RM, Eed AA, Gorin YC, et al. Nox4-derived reactive Oxygen species mediate cardiomyocyte injury in early type 1 diabetes [ J ]. A J Physiol Cell Physiol, 2012, 302(3) : C597-C604. 被引量：1
7Saliaris AP, Amado LC, Minhas KM, et al. Chronic allopurinol admin- istration ameliorates maladaptive alterations in Ca2 + cycling proteins and beta-adrenergic hyporesponsiveness in heart failure [ J ]. A J Physiol Heart Cireulat Physiol, 2007, 292(3) : H1328-H1335. 被引量：1
8Pacher P, Rajesh M, Mukhopadhyay P, et al. Xanthine oxidase inhibi- tor allopurinol attenuates the development of diabetic cardiomyopathy [J]. FASEB J, 2009, 23(8b) : 2330-2441. 被引量：1
9Liu VW, Huang PL. Cardiovascular roles of nitric oxide : a review of in- sights from nitric oxide synthase gene disrupted mice [ J ]. Cardiovascu- lar Research, 2008, 77 ( 1 ) : 19-29. 被引量：1
10Elomar MM, Lord R, Draper NJ, et al. Role of nitric oxide in posthy- poxic contractile dysfunction of diabetic cardiomyopathy [ J ]. Europ J Heart Failure, 2003, 5(3) : 229-239. 被引量：1
4Battiprolu PK, Lopez-Crisosto C, Wang ZV, et al. Diabetic cardiomyopathy and metabolic remodeling of the heart[J]. Life Sci, 2013, 92: 609-615. 被引量：1
5Roul D, Reechia FA. Metabolic alterations induce oxidative stress in diabetic and failing hearts: different pathways, same outcome: a brief review [J]. AntioxidRedox Signal, 2015, 22: 1502- 1514. 被引量：1
6Karasu C. Glycoxidative stress and cardiovascular complications in experimentally-induced diabetes: effects of antioxidant treatment [J]. Open Cardiovasc Med, 2010, 4: 240-256. 被引量：1
7Pop-Busui R, Stevens MJ, Raffel DM, et al. Effects of triple antioxidant therapy on measures of cardiovas- cular autonomic neuropathy and on myocardial blood flow in type l diabetes: a randomised controlled trial[J]. Diabetofogfa, 2013, 56: 1835-1844. 被引量：1
8Suzuki Y, Mitsushima S, Kato A, eta1. High-phosphorus/ zinc-free diet aggravates hypertension and cardiac dysfunction in a rat model of the metabolic syndrome [J]. Cardiovase Pstho7, 2014, 2: 43-49. 被引量：1
9Kelishadi R, Hashemipour M, Adeli K, et al. Effect of zinc supplementation on markers of insulin resistance, oxidative stress, and inflammation among prepubescent children with metabolic syndrome[J]. Metab Syndr Relat Disord, 2010, 8: 505- 510. 被引量：1
10Liu Y ,Chen C , Summers S, et al. C-peptide and zinc delivery to erythrocytes requires the presence of albumin: implications in diabetes explored with a 3D-printed fluidic device [J]. fntegrB/ol (Cash), 2015,7: 534-543. 被引量：1
